Springhill Fund Asset Management (HK) Co Ltd
CIK 1911270
13F portfolio (2025-Q1)
$21M
Positions
19
As reported on this filer's Form 13F for 2025-Q1, filed 2025-10-09. Long positions in SEC Section 13(f) securities; a lagged quarterly snapshot, filed up to 45 days after quarter-end. This filer has stopped filing 13F reports.
| 1 | VRNA | VERONA PHARMA PLC |
| 2 | SMMT | SUMMIT THERAPEUTICS INC |
| 3 | JANX | JANUX THERAPEUTICS INC |
| 4 | REGN | REGENERON PHARMACEUTICALS |
| 5 | NBIX | NEUROCRINE BIOSCIENCES INC |
Top holdings — weights and history with Pro
This 13F filer is outside the free plan's window — the 50 largest filers by portfolio value plus our curated roster of managers. It is in neither group. Unlock everything with Pro — $29.99/moSee it live on AAPL →